ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: DeVita Changes His Mind, Agrees To Head Treatment DIV; Contracts Chief Carl Fretts Moves Up To NIH

October 4, 1974

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Clinical Trials Approved By NCI

March 26, 2004

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

May 25, 1979

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000